Commentary on Covid-19: Who has priority for bivalent vaccines on October 3?  by Isabella

Commentary on Covid-19: Who has priority for bivalent vaccines on October 3? by Isabella

Covid-19: Who has priority for bivalent vaccines on October 3?
Some French have a preference to benefit from the new bivalent vaccines against Omicron. © Stock of Adobe.

Health Minister François Braun acknowledges the “resumption of virus circulation”. Vaccination campaign with “new bivalent vaccines against Omicron” starts on October 3. Who can benefit from it?

Where can I find these bivalent vaccines?

“For three weeks we have witnessed the resumption of the circulation of the virus”, acknowledged the French Minister of Health on September 27 French information. The new ones bivalent vaccines will be available from October 3rd. These vaccines are effective both “against the wild strain but also against Omicron”. They will be available “within pharmacieson vaccination centers“, suggested François Braun.

Who will have priority?

François Braun calls for “a new booster dose for target population groups”. These “target population“are:

  • them over 60,
  • people brittle,
  • people who are in contact with vulnerable people,
  • them health professionals,

Second booster with bivalent vaccine does not apply to the general population, says the minister. “Of course, if you want to get vaccinated, you can,” he added.

What is the situation at the hospital?

More 30,000 new contaminations were identified every day on average. The aftermath are still “uncertain” in hospital and varies greatly from region to region. Nationally, they have Covid-related hospitalizations increased by 8% in one week according to data from Public Health France on September 26.

“We put on a mask”

Wearing a mask is a civic gesture towards fragile people recalls François Braun. “When we’re together, it’s more without reason to put on a mask. When you are with a very fragile person, you put on a mask.

Author Image
adel

Leave a Reply

Your email address will not be published. Required fields are marked *